12.07.2015 Views

2011LamPharmacotherapyFormulationsoralantineoplastic

2011LamPharmacotherapyFormulationsoralantineoplastic

2011LamPharmacotherapyFormulationsoralantineoplastic

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

EXTEMPORANEOUS PREPARATION OF ORAL LIQUID ANTICANCER DRUGS Lam19Table 1. (continued)Storage and Stability, and Label Information Codes a CommentsNo data; drink the liquid immediately, then A, D, F If necessary, the suspension preparation may be used forrinse the glass with 15 ml of juice to ensureadministration through a nasogastric tube at discretion ofadministration of complete dose; any unusedthe physiciansuspension should be discarded 0 min afterDo not disperse the tablets or solution in grapefruit juicepreparationNo data; drink the liquid immediately, then A, D, F Do not disperse the tablets or solution in grapefruit juicerinse the glass with half a glass of water andconsume to ensure administration of full doseNo data A Capsule should be taken 1 hr before or 2 hrs after mealsMilk, milk products, calcium-containing products,magnesium, or other polyvalent ions should not be takenconcomitantly with estramustine due to impairment ofestramustine absorptionMethod 1: 22 days at room temperature A, D, F, J Etoposide at 1 mg/ml has acceptable stability whenregardless of lighting conditionsMethod 2: No dataadministered orally in orange juice, apple juice, andlemonade (not grapefruit juice) or flavored syrup with lessthan 1% loss over a 3-hr period. At this concentration,etoposide tends to precipitate out of solution; however,there was no loss of potency. To prevent precipitation,administer etoposide at concentrations ≤ 0.4 mg/ml.Bioavailability of oral administration of i.v. etoposide andorally swallowed capsules is comparableDo not disperse the capsules or drink solution in grapefruitjuiceCapsules need to be refrigeratedDoses should be taken 1 hr before or 2 hrs after mealsNo data A No pharmacokinetic data are available. Crushing is notrecommended; decision to crush or split tablet is based onclinical judgment.No data A No pharmacokinetic data are available. Crushing is notrecommended; decision to crush or split tablet is based onclinical judgment.Do not disperse the tablets or solution in grapefruit juiceNo data A, C, F Women who are or may become pregnant, or arebreastfeeding should not handle crushed or broken tabletsbecause it may cause abnormalities of a male baby’s sexorgans. Tablets are coated and will prevent contact withactive ingredient during normal handling.No dataANo data A, B, E, F Contents of capsule may be opened and mixed withapplesauce, pudding, or other soft foods, but not liquidsDo not disperse the tablets or solution in grapefruit juiceNo data; drink the liquid immediately, then A, D, F Oral liquid may be administered by a nasogastric tuberinse the glass with half a glass of water andDo not disperse the tablets or solution in grapefruit juiceconsume to ensure administration of full dose3–9 mo at room temperature (only 5% loss in A, B, E, Do not use heated water to prepare the solution sincechemical activity over first 3 mo, and no F, I mildly heated water (41°C) can immediately reduceadditional loss out to 9 mo of room chemical stability by 40%temperature storage)No data; drink the liquid immediately, then A, D, F Do not disperse the tablets or solution in grapefruit juicerinse the glass with half a glass of water orapple juice and consume to ensureadministration of full dose

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!